{"name":"InDex Pharmaceuticals","slug":"index-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"InDex Pharmaceuticals is a biotechnology company focused on the development of novel treatments for inflammatory diseases. The company's lead candidate, Cobitolimod, has been evaluated in various formulations and dosages, with some programs discontinued and others in early stages of clinical development.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxQNFhnaWxOdHVBTG5HMnQ1SGJxbGdkeENaWVM5WlVBcmhwVG1oUERfcVlTb2gyWE5kYjZqZGxUUWpib2tuc3U3VEIwdVQxemd6a2pYWVp2bU1nUmtKQm5hd2JWODR1SU9rSVRwQmdDSDBwY3ZUUy1VQWo1XzZhNEJISE9jS0U5ZlhSQ1lIRjVtUmh6bXBFN0UyZE9uY2lLTVlkZjkwTWVPb1Q3QndPZEN4R2ZDaVV4bTVOU2ZlV0lmeUdUT3lLZ2twMmg1OVrSAdIBQVVfeXFMT3dZNmVMMzFkSDRLdE53RVotX1dKYi1NLXVIanhTRVQxdWpjVTFJRnA0azZPU2RINFpiQ0FMTkw3bXl1d05WRUpvdTJaM2ZiS1pKekxhYVNiSGlXWlBEdVhwcG8zdVVtS0hLOWpFcnhjMWxLbC03b201T3NTVlRmT2RZbEdsNWk4NVBYRURwaVV1cWo3VkdfY1VNMGZlUWN2SHY5VkFJSjd3bXM0bDR2VEhiS2d3ZWw1Ml9tbXNoR1k0OTJ5UlpBYnBlcldVV3FvVlpR?oc=5","date":"2026-03-11","type":"pipeline","source":"Business Standard","summary":"Nifty Pharma index hits 52-week high; Ipca, Aurobindo rally up to 4% - Business Standard","headline":"Nifty Pharma index hits 52-week high; Ipca, Aurobindo rally up to 4%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPX2JpTzVtLVJTSUNUWGxNS2QxRHh6NlliM0IxcjhfX2JOMVVoSXhNRlV3R1F0ZEVPb2VuZDVFM0p1SGhoM0VKclhoUFI0QXk2TVFCTzVzU21mWmpCel9LTFFKNGp1ZHpBM2REdVk1MFlNeWJsbEZsdHRQUW12YnVwT1V1RTRNWFNVVFZsYUZpMWIta1dmclg1MUxuMU84Sm9OVmV2bEdrOA?oc=5","date":"2026-01-20","type":"pipeline","source":"Investing News Network","summary":"Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network","headline":"Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxNazh2WTVKU1lfWmVSNjRONVFmTUh1TDZycU5CSGU0Q3ZCSW4yM0VONjktemk2QlRhdFFPaUFFdW5zQjZXWmxNaFcySlFTc05DRFVQcjg2b1pyYk1EbG92cDZWTXNkalJENGZ1bnRGTl9jUDBJMFVXa2hrbllyTkoxQ05HUEswZUtXNk16TmhvNWJvdG1RWXVINQ?oc=5","date":"2026-01-09","type":"pipeline","source":"PwC","summary":"Future of Pharma: Breakthroughs at Scale - PwC","headline":"Future of Pharma: Breakthroughs at Scale","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-19","type":"pipeline","source":"South China Morning Post","summary":"China’s pharmaceutical industry transforms into a global innovation powerhouse - South China Morning Post","headline":"China’s pharmaceutical industry transforms into a global innovation powerhouse","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNcC1QVmNlY0d1bndLRTB3N0xBQkNLTzVqMDlSamVaZ3BEZUthd3YtaFlqZmRxaExkZG1qTzhIaG5sOVVLbUZicGM2WjQyQVhUU3BkTGFYTWJsdE9yNW4xTkRMTUJ1TW5ZamVYcnptWVRqblFuT3N1UG40RGNDUm1xZVBiakktVndEZmZtSTl0R1c4UGZSYWZtYUhucTJUWk1QSXc?oc=5","date":"2025-12-19","type":"pipeline","source":"Voronoi by Visual Capitalist","summary":"Top 30 Innovative and Inventive Pharma Companies in China - Voronoi by Visual Capitalist","headline":"Top 30 Innovative and Inventive Pharma Companies in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxPNGZWZmdSWkVsUGlzc0N4MWZkTzFhVXZ2LVo0aHcxRm5CSk1WemlPeHNmSG90RDVablVtX3BSUlFwdTRRLTh2bnlNdHFpdXNXUm9HZDlRWUU5MGFvWDQ3bzZ3OHNRQWNITmVaX1dGLTk1bTlUME9UMWdSSlpxZ3RscER0SUozd0JSUk04OEVvdTR5S185LVFCcnpkQ0xmZE5VQWsxSkhldXowQzJzWnQ3alJJOVRsTWZLbGVHc0xmQjRTSktHZUdjaGVTOFYzWEFob0cyNjRtbDdJYlp0WDBNeTBudGlfWFN2LUE4MnVMdF_SAfYBQVVfeXFMTjZJZmR6M3Q4X3Z4VG5qU2dLTk1OVmJ4U0M4SHN5TFprSmRjM3RkLUVHZnhXbzUyU1cxVTduSVBkRnBEUnJoMkZLUHJnNjJ6OWZBSFdJcUdBeTh3STdDN1Jnc01HT3BJSjhoNW1IR0J1eTFLbnFnbnY5dElHeVhtVnc1TDloNUhJQ3dHX0NHNTRLaVdKaDhFRnZYTlgyODNpTFRFX3ktT0FWNEtadXBFamdYTEttdU56Qld5NzdwZjRQOFlNUm1aVm9tUUFMNkxBVV8zYlBHUEVTOVAtSG51S3V6OE1tN3dKaGw3MmFMdVRlTEhzUkFR?oc=5","date":"2025-10-10","type":"pipeline","source":"Mint","summary":"Divi’s Laboratories, Piramal Pharma to Laurus Labs: Why are pharma stocks skyrocketing today? - Mint","headline":"Divi’s Laboratories, Piramal Pharma to Laurus Labs: Why are pharma stocks skyrocketing today?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTFBNRTRnMUIwOUxkNWhSeXc3aWtHdTFVZjZhdEZ2WDdaVE9ZS3VlaEl6c201Zml6UnpjTHhXOTk1WkJLQmFzQWRDcUtGTDVjcTFBRXZ2NWY4ZERrLVZUUm15bDR3TVhVMnFEdDVvWU82bw?oc=5","date":"2025-10-07","type":"pipeline","source":"PharmaLive","summary":"The 2025 Outcomes Creativity Index - PharmaLive","headline":"The 2025 Outcomes Creativity Index","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxQeXRqNW1Yd0hoR0dBYi1mM01jWXlhUUdNSkJlZ0ppcHNXOC1FVlhYWFpWU04yaDhOTi1KcFItWkNyOGRqOWF4dGJReXZoOGxjMkF0TDVzWUZucjM2TThSb0pqaW1RVWhueklzdmdFYzhBT1dxb0tzdnlWMlBSZ08ydW9SdHc5eUNkeHVlTWRGUjZzUDJ1MUpsZjNtYjBvWjI2ckxwNzBPd3NxY2sxVHFSaVdCa2U0S0QyOW4tSlI1Y19rTHFQS1lhYjRaWFZvYmFwdVhrTjhjaGhtVmNLMW1mMkJGQmVIamQzbWhYWVBYNHlPaUJhckFCZEthZ04?oc=5","date":"2025-09-15","type":"pipeline","source":"TradingView","summary":"Pharma index snaps four-day rally as Dr Reddy's, Biocon, other shares slide up to 2 percent: Factors at play - TradingView","headline":"Pharma index snaps four-day rally as Dr Reddy's, Biocon, other shares slide up to 2 percent: Factors at play","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-09","type":"pipeline","source":"Moneycontrol.com","summary":"Pharma stocks in green even as Trump threatens 200% tariffs; Lupin, Biocon lead gains - Moneycontrol.com","headline":"Pharma stocks in green even as Trump threatens 200% tariffs; Lupin, Biocon lead gains","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOcmpCVnFxSW9OZEtGMTJuX0hrUFhZYnRhUzFicVlpdUY5OVV0OUdiQmprZ0psd0xqRjRzU05xVjI1S2p3YXpnVUZFeC1CY20xcnRUWkw5UEotbzZ4TkNza2M3eDRRdV9ENldiTU5kUEdvNk9vc3EwWHRRNWZHQmY4UF9mZ0hveldiQXJXQ0E4a2QydllYMFlCUUNISFJ3RzhjVzhGNGhrUElUVU1aYUt1UHJfTFNXUmY3bXFWQ2ZkMA?oc=5","date":"2025-05-20","type":"pipeline","source":"Fierce Pharma","summary":"As Eli Lilly outperforms Novo in market, it also replaces its rival in annual IDEA Innovation rankings - Fierce Pharma","headline":"As Eli Lilly outperforms Novo in market, it also replaces its rival in annual IDEA Innovation rankings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNbU1vS2tSVDN0NU5fS2N6YnlORmxxV3VZYnF6dGhVd0ZJUXRzdm5mUHJQVi0yQkN6TkVNN1ZvVDc0cldLSXo1OXVJWHFTb0RKZ05NX0k3Rlc5NkZnS1g5d1czdlZuTDU0YVJmdGZmcXhMRnlMZnJYS1Y5SjFnZmRNbU9fYndpOHlfS1RRZnRsa2xoOXEyUjdQZjR4N3ZpYnc1RjdURWpvbEl5b3NMWUc3cTA3LUdVaXVuM2t2VzRfeVBtck4tY2dBZkhmRWlHQk02RWc?oc=5","date":"2025-04-09","type":"pipeline","source":"Reuters","summary":"Global pharma shares plunge as Trump doubles down on tariff threat - Reuters","headline":"Global pharma shares plunge as Trump doubles down on tariff threat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE8tdlZaQndVa0VOank2NWxraGwxUGZaUVBSNV9xSTRYT3dPRHdBbzZ4QVE0RXVDcEU0VE9PVkg5anVLelV4YlVhcXJ5blJlUnhRNk9aZURObldNTVN0TTR1YThXR293R0NURm1IZTNJNFdkbF8yVFQ3bEN0VV9fdw?oc=5","date":"2024-05-16","type":"pipeline","source":"statnews.com","summary":"Analysis of pharmaceutical R&D ranks Novo Nordisk and Johnson & Johnson above their peers - statnews.com","headline":"Analysis of pharmaceutical R&D ranks Novo Nordisk and Johnson & Johnson above their peers","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}